☆ 4.5 Article

Transforming growth factor beta-3 localization in the corneal response to epithelial-stromal injury and effects on corneal fibroblast transition to myofibroblasts

EXPERIMENTAL EYE RESEARCH (2023)

Related references

Note: Only part of the references are listed.

Article Ophthalmology

Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders

Steven E. Wilson

Summary: Losartan, an angiotensin II receptor blocker, inhibits TGF beta signaling by blocking ERK activation. Studies have shown its efficacy in reducing scarring fibrosis in various eye injuries and complications. Clinical studies are needed to explore its effectiveness and safety in treating corneal scarring fibrosis and other eye diseases involving TGF beta. It has the potential to enhance pharmacological therapeutics for ocular diseases where TGF beta plays a central role.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2023)

Add to Collection

Article Ophthalmology

Cell Biology of Spontaneous Persistent Epithelial Defects After Photorefractive Keratectomy in Rabbits

Lycia Pedral Sampaio et al.

Translational Vision Science & Technology (2023)

Add to Collection

Article Ophthalmology

The corneal fibroblast: The Dr. Jekyll underappreciated overseer of the responses to stromal injury

Steven E. Wilson

Summary: Corneal fibroblasts play a crucial role in wound healing, originating from keratocytes.Transforming growth factor (TGF)-01 and TGF02, along with platelet-derived growth factor (PDGF), regulate the transition of keratocytes to corneal fibroblasts.Coronal fibroblasts perform various functions in damaged cornea, including basement membrane (BM) regeneration, control of TGF0 effects on stromal cells, attraction of bone marrow-derived cells, modulation of epithelium regeneration, and contribution to stromal integrity.

OCULAR SURFACE (2023)

Add to Collection

Article Ophthalmology

Epithelial Basement Membrane Regeneration After PRK-Induced Epithelial-Stromal Injury in Rabbits: Fibrotic Versus Non-fibrotic Corneal Healing

Rodrigo Carlos de Oliveira et al.

Summary: The study aims to investigate EBM regeneration in non-fibrotic and fibrotic corneas after PRK. It was found that defective perlecan incorporation in fibrotic corneas can lead to incomplete EBM regeneration, while fully regenerated EBM in non-fibrotic corneas is associated with restoration of corneal transparency.

JOURNAL OF REFRACTIVE SURGERY (2022)

Add to Collection

Article Ophthalmology

Topical losartan inhibits corneal scarring fibrosis and collagen type IV deposition after Descemet's membrane-endothelial excision in rabbits

Lycia Pedral Sampaio et al.

Summary: The study showed that topical losartan can reduce central stromal opacity intensity, peripheral corneal scarring, and decrease alpha-smooth muscle actin myofibroblast fibrosis area. Additionally, topical losartan can also decrease posterior stromal cellular collagen type IV production.

EXPERIMENTAL EYE RESEARCH (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Corneal fibroblast collagen type IV negative feedback modulation of TGF beta: A fibrosis modulating system likely active in other organs

Steven E. Wilson et al.

Summary: Collagen type IV plays a key role in controlling the pro-fibrotic effects of transforming growth factor beta. It binds TGF beta and regulates its function in various organs. Losartan, a known TGF beta signaling inhibitor, can alter the production of collagen type IV and potentially mitigate the effects of TGF beta. Similar pathways may exist in other organs as well.

MATRIX BIOLOGY (2022)

Add to Collection

Article Ophthalmology

Topical Losartan and Corticosteroid Additively Inhibit Corneal Stromal Myofibroblast Generation and Scarring Fibrosis After Alkali Burn Injury

Lycia Pedral Sampaio et al.

Summary: This study evaluated the efficacy of losartan and prednisolone acetate in inhibiting corneal scarring fibrosis after alkali burn injury in rabbits. The results showed that the combined use of these two drugs significantly reduced opacity area and intensity, decreased myofibroblast area and staining intensity, and confined myofibroblasts to the posterior stroma while promoting repopulation of the anterior and mid-stroma with keratocan-positive keratocytes. Furthermore, topical losartan reduced the production of collagen type IV. These findings suggest that topical losartan and prednisolone acetate can effectively decrease myofibroblast-mediated scarring fibrosis after corneal injury.

TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2022)

Add to Collection

Article Ophthalmology

Magic Bullets: The Coming Age of Meaningful Pharmacological Control of the Corneal Responses to Injury and Diseae

Steven E. Wilson

Summary: For the treatment of corneal pathophysiology associated with epithelial healing disorders, stromal scarring fibrosis, corneal neovascularization, and corneal endothelial injury, several medications, such as nerve growth factor, losartan, tyrosine kinase inhibitors, and Rho-kinase inhibitors, have shown potential efficacy and are in various stages of clinical trials.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2022)

Add to Collection

Article Ophthalmology

TGFβ1 and TGFβ2 proteins in corneas with and without stromal fibrosis: Delayed regeneration of apical epithelial growth factor barrier and the epithelial basement membrane in corneas with stromal fibrosis

Rodrigo Carlos de Oliveira et al.

Summary: The study aimed to investigate the expression and localization of TGF beta 1 and TGF beta 2 in rabbit corneas with and without stromal fibrosis, as well as defective perlecan incorporation in the epithelial basement membrane. The findings revealed delayed regeneration of epithelial and EBM barriers in high injury corneas, leading to increased myofibroblast development and stromal fibrosis. Corneas with more severe injuries showed prolonged myofibroblast viability and triggered stromal scarring fibrosis due to delayed regeneration of epithelial and EBM barriers.

EXPERIMENTAL EYE RESEARCH (2021)

Add to Collection

Article Ophthalmology

Descemet's membrane injury and regeneration, and posterior corneal fibrosis, in rabbits

Lycia Pedral Sampaio et al.

Summary: This study investigated Descemet's membrane and corneal endothelial regeneration, myofibroblast generation and disappearance, and TGF beta-1 localization after Descemetorhexis in rabbits. The results showed that stromal transparency increased over time, myofibroblast zone thickness peaked at one month post-injury and then decreased, and TGF beta-1 deposition peaked at one day post-injury and decreased before regeneration of the endothelium and Descemet's membrane.

EXPERIMENTAL EYE RESEARCH (2021)

Add to Collection

Article Infectious Diseases

Automated Western immunoblotting detection of anti-SARS-CoV-2 serum antibodies

Sophie Edouard et al.

Summary: ELISA and chemiluminescence serological assays for COVID-19 currently focus on one or two SARS-CoV-2 antigens, while an automated Western immunoblotting was developed as a complementary serologic assay, using an inactivated SARS-CoV-2 lineage 20a strain as the antigen source. The automated Western immunoblotting showed substantial agreement (90%) with the compared ELISA, with a sensitivity of 94% and a specificity of 93%, particularly in samples collected more than 2 weeks after symptom onset.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)

Add to Collection

Article Ophthalmology

TGF beta-1,-2 and-3 in the modulation of fibrosis in the cornea and other organs

Steven E. Wilson

Summary: The TGF beta-1, -2 and -3 isoforms, transcribed from different genes, share the same regulatory mechanisms and signal transduction pathways. Despite the traditional belief that TGF beta-1 and TGF beta-2 are pro-fibrotic while TGF beta-3 is anti-fibrotic, this review suggests that TGF beta-3 actually shares more similarities in regulating fibrotic gene expression with TGF beta-1 and TGF beta-2. The complex interplay between these three isoforms and various proteins controls the healing process in response to injury and the resolution of fibrosis in different organs.

EXPERIMENTAL EYE RESEARCH (2021)

Add to Collection

Review Ophthalmology

Interleukin-1 and Transforming Growth Factor Beta: Commonly Opposing, but Sometimes Supporting, Master Regulators of the Corneal Wound Healing Response to Injury

Steven E. Wilson

Summary: This review highlights the interactions and regulatory roles of interleukin (IL)-1 and transforming growth factor (TGF) beta in the corneal wound healing process. Both systems play crucial roles in regulating cellular functions and gene expressions during the healing response to injuries or infections, and their coordinated downregulation is necessary to terminate the response and prevent fibrosis in the cornea. Understanding the IL-1 and TGF beta systems better can lead to improved approaches for controlling excessive healing responses and scarring corneal fibrosis caused by infections and injuries.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2021)

Add to Collection

Review Cell Biology

TGF-β receptors: In and beyond TGF-β signaling

Alexandra Vander Ark et al.

CELLULAR SIGNALLING (2018)

Add to Collection

Article Cell Biology

Non-Smad Signaling Pathways of the TGF-β Family

Ying E. Zhang

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)

Add to Collection

Article Ophthalmology

PDGFRα Is a Key Regulator of T1 and T3's Differential Effect on SMA Expression in Human Corneal Fibroblasts

Sriniwas Sriram et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)

Add to Collection

Article Ophthalmology

Molecular insights on the effect of TGF-β1/-β3 in human corneal fibroblasts

Xiaoqing Guo et al.

EXPERIMENTAL EYE RESEARCH (2016)

Add to Collection

Article Cell Biology

Transforming growth factor beta (TGF-β) isoforms in wound healing and fibrosis

Michael K. Lichtman et al.

WOUND REPAIR AND REGENERATION (2016)

Add to Collection

Article Cell Biology

TGF-β Signaling from Receptors to Smads

Akiko Hata et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)

Add to Collection

Article Cell & Tissue Engineering

Restoration of Corneal Transparency by Mesenchymal Stem Cells

Sharad K. Mittal et al.

STEM CELL REPORTS (2016)

Add to Collection

Article Ophthalmology

Reversal of fibrosis by TGF-β3 in a 3D in vitro model

D. Karamichos et al.

EXPERIMENTAL EYE RESEARCH (2014)

Add to Collection

Article Ophthalmology

TGFβ and PDGF-B signaling blockade inhibits myofibroblast development from both bone marrow-derived and keratocyte-derived precursor cells in vivo

Vivek Singh et al.

EXPERIMENTAL EYE RESEARCH (2014)

Add to Collection

Article Ophthalmology

Transforming growth factor β and platelet-derived growth factor modulation of myofibroblast development from corneal fibroblasts in vitro

Vivek Singh et al.

EXPERIMENTAL EYE RESEARCH (2014)

Add to Collection

Article Engineering, Biomedical

The engineering of organized human corneal tissue through the spatial guidance of corneal stromal stem cells

Jian Wu et al.

BIOMATERIALS (2012)

Add to Collection

Review Cell Biology

Non-Smad signaling pathways

Yabing Mu et al.

CELL AND TISSUE RESEARCH (2012)

Add to Collection

Review Cell Biology

Role of Smads in TGF beta signaling

Carl-Henrik Heldin et al.

CELL AND TISSUE RESEARCH (2012)

Add to Collection

Article Peripheral Vascular Disease

Hepatocyte Growth Factor Reduces Cardiac Fibrosis by Inhibiting Endothelial-Mesenchymal Transition

Keita Okayama et al.

HYPERTENSION (2012)

Add to Collection

Article Ophthalmology

Growth Factor Regulation of Corneal Keratocyte Mechanical Phenotypes in 3-D Collagen Matrices

Neema Lakshman et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)

Add to Collection

Article Ophthalmology

Effect of TGFβ and PDGF-B blockade on corneal myofibroblast development in mice

V. Singh et al.

EXPERIMENTAL EYE RESEARCH (2011)

Add to Collection

Article Cell & Tissue Engineering

Transforming growth factor-β3 regulates assembly of a non-fibrotic matrix in a 3D corneal model

D. Karamichos et al.

JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2011)

Add to Collection

Article Cell Biology

TGFβ Mediated Transition of Corneal Fibroblasts From a Proinflammatory State to a Profibrotic State Through Modulation of Histone Acetylation

Qingjun Zhou et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2010)

Add to Collection

Article Medicine, General & Internal

Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies

Mark W. J. Ferguson et al.

LANCET (2009)

Add to Collection

Review Oncology

Regulation of TGF-β family signaling by E3 ubiquitin ligases

Yasumichi Inoue et al.

CANCER SCIENCE (2008)

Add to Collection

Article Pathology

Of mice and dogs: Species-specific differences in the inflammatory response following myocardial infarction

O Dewald et al.

AMERICAN JOURNAL OF PATHOLOGY (2004)

Add to Collection

Review Multidisciplinary Sciences

Smad-dependent and Smad-independent pathways in TGF-β family signalling

R Derynck et al.

NATURE (2003)

Add to Collection

Article Ophthalmology

TGFβ induced myofibroblast differentiation of rabbit keratocytes requires synergistic TGFβ, PDGF and integrin signaling

JV Jester et al.

EXPERIMENTAL EYE RESEARCH (2002)

Add to Collection

Article Biochemistry & Molecular Biology

Proteoglycan expression during transforming growth factor β-induced keratocyte-myofibroblast transdifferentiation

JL Funderburgh et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Add to Collection

Article Biochemistry & Molecular Biology

Functional roles for the cytoplasmic domain of the type III transforming growth factor β receptor in regulating transforming growth factor β signaling

GC Blobe et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.